Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.
作者信息
Doyle Andrew J, Springell Deborah, Dutt Tina, Kenworthy Jessica, Ling Gavin, Desborough Michael, Thomas William, Hermans Joannes, Vanveen Joost, Cranfield Tanya, Belsham Edward, Hill Quentin A, Lester Will, Scully Marie
机构信息
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Department of Haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
出版信息
J Thromb Haemost. 2022 Mar;20(3):781-783. doi: 10.1111/jth.15632.
Abstract
摘要
相似文献
1
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.获得性血栓性血小板减少性紫癜：一种与BNT162b2疫苗相关的罕见疾病：多伊尔等人的评论
J Thromb Haemost. 2022 Mar;20(3):781-783. doi: 10.1111/jth.15632.
2
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Reply to comment from Doyle et al.获得性血栓性血小板减少性紫癜：一种与BNT162b2疫苗相关的罕见疾病：对多伊尔等人评论的回复
J Thromb Haemost. 2022 Mar;20(3):783-784. doi: 10.1111/jth.15634.
3
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
4
Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient.日本患者接种 BNT162b2 mRNA 冠状病毒病疫苗后获得性血栓性血小板减少性紫癜。
Intern Med. 2022 Feb 1;61(3):407-412. doi: 10.2169/internalmedicine.8568-21. Epub 2021 Nov 20.
5
Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.接种 BNT162b2 新冠疫苗后获得性血栓性血小板减少性紫癜：病例报告和文献复习。
Lab Med. 2022 Nov 3;53(6):e145-e148. doi: 10.1093/labmed/lmac016.
6
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.儿童期和青少年期起病的获得性血栓性血小板减少性紫癜伴严重ADAMTS13缺乏症：法国全国血栓性微血管病登记处的一项队列研究
Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.
7
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine.BNT162b2疫苗接种后免疫介导的血栓性血小板减少性紫癜
Turk J Haematol. 2022 Feb 23;39(1):74-75. doi: 10.4274/tjh.galenos.2021.2021.0537. Epub 2021 Dec 10.
8
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.首次接种BNT162b2 mRNA新冠疫苗后发生获得性血栓性血小板减少性紫癜。
Ann Hematol. 2022 Mar;101(3):717-719. doi: 10.1007/s00277-021-04584-y. Epub 2021 Jul 26.
9
A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.一例以妊娠期血栓性血小板减少性紫癜为表现的严重ADAMTS13缺乏症病例。
Med Pregl. 2012 Sep-Oct;65(9-10):436-9. doi: 10.2298/mpns1210436n.
10
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.孕期表现为免疫性血小板减少性紫癜的遗传性血栓性血小板减少性紫癜：一例报告
J Med Case Rep. 2018 Jan 22;12(1):15. doi: 10.1186/s13256-017-1545-3.
引用本文的文献
1
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.接种 COVID-19 疫苗后的血栓性血小板减少性紫癜（TTP）：已报告病例的系统评价。
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.
本文引用的文献
1
ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis.采用血浆置换成功治疗ChAdOx1 nCov-19疫苗诱导的血栓性血小板减少性紫癜。
Ann Hematol. 2022 May;101(5):1123-1124. doi: 10.1007/s00277-021-04701-x. Epub 2021 Oct 18.
2
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab.一名青少年接种BNT162b2疫苗后出现血栓性血小板减少性紫癜，使用卡泊单抗成功治疗。
Br J Haematol. 2022 Jan;196(1):e11-e14. doi: 10.1111/bjh.17782. Epub 2021 Aug 17.
3
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.疫苗诱导的免疫性血小板减少症和血栓形成的临床特征。
N Engl J Med. 2021 Oct 28;385(18):1680-1689. doi: 10.1056/NEJMoa2109908. Epub 2021 Aug 11.
4
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.血栓性血小板减少性紫癜：COVID-19 bnt162b2 疫苗接种后的新威胁
Int J Hematol. 2021 Nov;114(5):626-629. doi: 10.1007/s12185-021-03190-y. Epub 2021 Jul 15.
5
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
6
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.首例与基于 mRNA 的抗 COVID-19 疫苗接种相关的新发免疫性血小板减少性紫癜（iTTP）发作。
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
7
Exacerbation of immune thrombocytopenia following COVID-19 vaccination.接种 COVID-19 疫苗后免疫性血小板减少症恶化。
Br J Haematol. 2021 Nov;195(3):365-370. doi: 10.1111/bjh.17645. Epub 2021 Jun 24.
8
A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.一项病例对照研究，评估疫苗相关免疫性血小板减少症的风险。
Blood. 2012 Dec 13;120(25):4938-44. doi: 10.1182/blood-2012-05-431098. Epub 2012 Oct 24.
Zotero 插件